Skip to main content
Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · IEX Real-Time Price · USD
1.960
-0.160 (-7.55%)
At close: Jul 2, 2024, 4:00 PM
1.980
+0.020 (1.02%)
After-hours: Jul 2, 2024, 7:31 PM EDT

Immix Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
 Current20232022202120202019
Market Capitalization
521373226--
Market Cap Growth
220.36%331.07%24.43%---
Enterprise Value
2412018843
PE Ratio
--8.91-3.87-1.05--
PB Ratio
1.858.382.421.43--
P/FCF Ratio
-6.04-12.03-4.31-16.12--
P/OCF Ratio
-6.18-12.09-4.31-16.13--
EV/EBITDA Ratio
-2.91-7.79-2.25-0.33-3.61-4.00
EV/EBIT Ratio
-2.91-7.79-2.25-0.33-3.61-4.00
EV/FCF Ratio
-3.93-10.50-2.49-5.05-9.16-4.22
Debt / Equity Ratio
0.04--0.00-0.87-1.12
Debt / EBITDA Ratio
-0.06--0.00-4.00-4.87
Debt / FCF Ratio
-0.08---0.03-10.13-5.14
Quick Ratio
5.184.7010.5587.330.070.16
Current Ratio
5.825.3211.7090.010.100.20
Interest Coverage
---16537.12-134.54-10.08-7.66
Return on Equity (ROE)
-94.20%-100.90%-48.60%-367.80%27.40%-
Return on Assets (ROA)
-78.90%-86.70%-46.10%-260.30%-154.90%-
Return on Capital (ROIC)
-66.22%-98.39%-62.45%-7.49%71.97%-185.72%
Earnings Yield
-35.16%-11.22%-25.80%-95.13%--
FCF Yield
-25.92%-8.31%-23.23%-6.20%--
Buyback Yield / Dilution
-68.65%-24.87%-278.13%-8.82%--
Total Shareholder Return
-68.65%-24.87%-278.13%-8.82%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).